Chill Brands Group
CHLL · Main Market · Health Care · mcap £0.9m · 1.7p 2 open situations →
- EV
- £4.0m
- EV / EBIT
- –
- Net debt
- £3.2m
- FCF yield
- -184.0%
- Revenue
- £370k
- Share price 1y
- −85%
- Insiders 12m
- no deals
- Next report
- around 29 Jan
Open · 2
Liquidity and funding constraints
Led to Corporate and operational structure review – Early-stage talks; no course determined
Liquidity has been tight since January 2026, with the company drawing convertible loan and inventory facilities. The interims show cash down to £37,075, a further £540,000 drawn from the largest shareholder's £1.0m facility, finance costs of £273,939 and a £118,947 doubtful-debt provision. The Board calls related-party funding unsustainable and flags tax liabilities as a risk.
- Cash
- £37,075 at 31 March 2026 (£99,957 at 30 September 2025)
- Drawn in period
- £540,000 from the largest shareholder's working capital facility of up to £1.0 million
- Finance costs
- £273,939 (2025: £96,430)
- Board view
- Reliance on related-party funding is not a sustainable long-term position
- Other risk
- Historic tax liabilities under ongoing engagement with the tax authority
Next: secure funding or complete a strategic transaction
- 30 Jun 2026 Cash £37,075; reliance on shareholder loan facility
- 9 Feb 2026 Liquidity flat; drawing convertible loan and inventory facilities
- 30 Jan 2026 Tight liquidity; funding requirements acknowledged
Corporate and operational structure review
Follows from Liquidity and funding constraints – Cash £37,075; reliance on shareholder loan facilityPart of chill.com digital platform partnership – Early-stage; included in wider talks
The structure review began in February 2026 and is now a strategic review of partnerships, investments and transactions. The interims tie it to strengthening the balance sheet and say no course is agreed and no commitments are made. The Board lists execution risk and no certainty of a suitable transaction.
- Status
- Early-stage discussions; no definitive course of action agreed
- Commitments
- None entered into
- Board ambition
- Larger, more diversified public company using the Main Market listing
- Aim
- Strengthen the balance sheet and enhance shareholder value
- Risk
- No certainty a suitable transaction will be identified, agreed or completed
- Terms
- None disclosed
Next: update shareholders on material developments
- 30 Jun 2026 Early-stage talks; no course determined
- 9 Feb 2026 Review under way
Company filings. Not investment advice.